Position in DHR
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$64,762
+$54,920 QoQ
Shares Held
340
+690.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,864
of 2,098 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cape Investment Advisory, Inc. holds $2,136,808 across 12 Diagnostics & Research names. DHR ranks #3 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
9,394 | $1,815,108 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
150 | $75,204 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
340 | $64,762 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
240 | $54,429 | |
| 5 | LH |
Labcorp Holdings Inc.
|
167 | $46,760 | |
| 6 | WAT |
Waters Corp /De/
|
102 | $38,254 | |
| 7 | ICLR |
Icon PLC
|
111 | $19,281 | |
| 8 | A |
Agilent Technologies, Inc.
|
47 | $6,242 |
All Filings in DHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,762 | 340 | Shares | Defined | 2026-07-23 | |
| 2025-12-31 | $9,842 | 43 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,154 | 26 | Shares | Sole | 2025-12-29 | |
| 2025-06-30 | $3,555 | 18 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $1,025 | 5 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $918 | 4 | Shares | Sole | 2025-02-05 | |
| 2023-12-31 | $25,447 | 110 | Shares | Sole | 2024-02-12 | |
| 2023-03-31 | $3,528 | 14 | Shares | Sole | 2023-10-12 | |
| No filing history on record for this holder in this stock. | ||||||